What is Zoster ophthalmicus visual disturbance?
Zoster ophthalmicus (ZO) is a re‑activation of the varicella‑zoster virus (VZV) that involves the ophthalmic branch (V1) of the trigeminal nerve. When the virus inflames the ocular structures—cornea, conjunctiva, iris, or optic nerve—it can produce a spectrum of visual disturbances, ranging from mild blurring to sudden vision loss. The condition is a medical emergency because permanent eye damage can occur within days if left untreated. Mayo Clinic.
Common Causes
Visual disturbance in the setting of Zoster ophthalmicus results from direct viral injury, secondary inflammation, or ischemic complications. The following conditions are often involved:
- Varicella‑zoster virus reactivation (the primary cause of ZO).
- Keratitis – inflammation of the cornea caused by viral invasion.
- Iritis/iridocyclitis – inflammation of the iris and ciliary body.
- Uveitis – inflammation of the middle layer of the eye.
- Acute retinal necrosis (ARN) – rapidly progressive necrosis of the retina.
- Optic neuritis – inflammation of the optic nerve leading to decreased acuity.
- Elevated intra‑ocular pressure (secondary glaucoma) due to trabecular meshwork blockage.
- Vasculitis of retinal vessels – can cause retinal hemorrhages and ischemia.
- Secondary bacterial infection (e.g., bacterial keratitis) that worsens vision.
- Post‑herpetic neuralgia affecting the corneal nerves leading to epithelial breakdown.
Associated Symptoms
Patients with Zoster ophthalmicus often experience a constellation of ocular and systemic signs:
- Burning, stabbing, or itching pain around the eye and forehead.
- Characteristic herpes zoster rash on the forehead, scalp, or tip of the nose (Hutchinson’s sign).
- Redness of the eye (conjunctival injection).
- Photophobia (painful sensitivity to light).
- Tearing or watery discharge.
- Foreign‑body sensation or gritty feeling in the eye.
- Drooping eyelid (ptosis) or facial weakness if the nerve involvement extends.
- Headache, fever, or malaise.
When to See a Doctor
Any new eye symptom in the setting of a shingles rash warrants prompt evaluation. Seek care immediately if you notice:
- Sudden or progressive loss of vision in one eye.
- Severe eye pain that does not improve with over‑the‑counter pain medication.
- Visible patches of white or gray on the cornea (suggesting keratitis).
- Persistent redness or swelling lasting more than 24–48 hours.
- Double vision, flashing lights, or new visual field deficits.
- History of immune suppression (e.g., HIV, chemotherapy, organ transplant).
Diagnosis
Diagnosing Zoster ophthalmicus with visual disturbance involves a combination of history, physical exam, and specialized ocular testing.
Clinical Evaluation
- History taking – onset of rash, pain pattern, prior shingles, immune status.
- External eye inspection – looking for Hutchinson’s sign, vesicular lesions, conjunctival injection.
- Slit‑lamp examination – magnified view of cornea, anterior chamber, and iris to detect keratitis, uveitis, or dendritic lesions.
Imaging & Laboratory Tests
- Fluorescein staining – highlights corneal epithelial defects.
- Fundus examination (indirect ophthalmoscopy) – assesses retina for vasculitis or ARN.
- Optical coherence tomography (OCT) – cross‑sectional imaging of retina and optic nerve.
- Polymerase chain reaction (PCR) of tear fluid or aqueous humor – confirms VZV DNA (useful in atypical cases).
- Blood work – CBC, ESR, CRP, and HIV testing if immunosuppression is suspected.
Treatment Options
Therapy aims to stop viral replication, reduce inflammation, control pain, and protect vision.
Antiviral Medications (first‑line)
- Acyclovir 800 mg five times daily for 7–10 days.
- Valacyclovir 1 g three times daily (more convenient dosing).
- Famciclovir 500 mg three times daily.
- Start antivirals within 72 hours of rash onset for maximal benefit CDC.
Corticosteroids
- Topical prednisolone acetate 1% drops for anterior uveitis (usually 4–6 times daily, tapered).
- Oral prednisone may be added for severe inflammation, but only after antiviral therapy is initiated.
Adjunctive Eye Care
- Artificial tears or lubricating ointments to prevent corneal drying.
- Cycloplegic agents (e.g., homatropine) for painful pupil constriction.
- Topical antibiotics if secondary bacterial infection is suspected.
- Intra‑ocular pressure‑lowering drops** (e.g., timolol) if glaucoma develops.
Pain Management
- Acetaminophen or ibuprofen for mild‑moderate pain.
- Neuropathic pain agents (gabapentin, pregabalin, or tricyclic antidepressants) for post‑herpetic neuralgia.
- Topical lidocaine 5% patches for localized ocular surface pain (use under ophthalmic guidance).
Hospital‑Based Care
Severe cases—particularly those with acute retinal necrosis, optic neuritis, or uncontrolled intra‑ocular pressure—may need intravenous antivirals (e.g., acyclovir 10 mg/kg every 8 h) and close monitoring in an ophthalmology unit.
Prevention Tips
- Shingles vaccine (Shingrix®) for adults ≥50 years or immunocompromised patients; it reduces the risk of VZV reactivation and associated eye disease CDC.
- Maintain good hand hygiene and avoid touching lesions to limit viral spread.
- Control chronic illnesses (diabetes, hypertension) that impair immunity.
- If you have a prior episode of shingles, discuss prophylactic antiviral therapy with your doctor during periods of immune stress.
- Regular eye examinations, especially if you have a history of VZV infection or immune suppression.
Emergency Warning Signs
- Sudden, painless loss of vision or a “shadow”/curtain over part of the visual field.
- Severe eye pain that worsens despite analgesics.
- Rapidly spreading redness, swelling, or a painful, hard eye (suggesting acute angle‑closure glaucoma).
- Development of white or gray patches on the cornea that enlarge quickly.
- Flashing lights, new floaters, or a “spider‑web” visual pattern (possible retinal involvement).
- Fever >101 °F (38.3 °C) with worsening ocular symptoms.
If any of these occur, go to an emergency department or eye‑care clinic **immediately**. Timely treatment can preserve sight.
Key Take‑aways
Zoster ophthalmicus is a potentially sight‑threatening manifestation of shingles. Prompt antiviral therapy, careful ophthalmic evaluation, and appropriate anti‑inflammatory treatment are essential to prevent permanent damage. Vaccination remains the most effective preventive strategy, and patients should never ignore visual changes or severe eye pain—early medical attention saves vision.
References:
- Mayo Clinic. Shingles eye complications. Link. Accessed May 2026.
- CDC. Shingles (Herpes Zoster) Treatment. Link. Accessed May 2026.
- National Institutes of Health. Varicella‑zoster virus ocular disease. PMCID. 2023.
- American Academy of Ophthalmology. Clinical Practice Guideline: Herpes Zoster Ophthalmicus. 2022.
- World Health Organization. Shingles vaccine recommendations. 2021.